Bionano Genomics Inc. Investors: Company Investigated by the Portnoy Law Firm

Investors can contact the law firm at no cost to learn more about recovering their losses

LOS ANGELES, April 17, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Bionano Genomics, Inc. (“Bionano”) (NASDAQ: BNGO) investors that the firm has initiated an investigation into whether Bionano issued false and misleading statements to investors.

Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: lesley@portnoylaw.com, to discuss their legal rights, or click here to join the case via https://portnoylaw.com/bionano/. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.

On or around April 17, 2023, Bionano issued and sold a Series A Preferred share with the equivalent of 3 million share voting power (the, “supervoting share”). The supervoting share was sold to Bionano Chairman of the Board David Barker. On this news the Company’s stock fell over 20% during intraday trading.

Please visit our website to review more information and submit your transaction information.

The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.

Lesley F. Portnoy, Esq.
Admitted CA and NY Bar
lesley@portnoylaw.com
310-692-8883
www.portnoylaw.com

Attorney Advertising